These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4087773)

  • 1. [Thrombocyte aggregation during adequate periodic hemodialysis].
    Kiriakov Z; Deliĭski M; Kamenov V; Ionova D
    Khirurgiia (Sofiia); 1985; 38(5):8-11. PubMed ID: 4087773
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced in vitro platelet aggregation in hemodialysis patients.
    Viener A; Aviram M; Better OS; Brook JG
    Nephron; 1986; 43(2):139-43. PubMed ID: 3713942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced platelet aggregation in chronic renal failure patients receiving hemodialysis treatment.
    Bemis J; Rigney J; Sosin A; Deane N
    Trans Am Soc Artif Intern Organs; 1977; 23():48-53. PubMed ID: 910370
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of azathioprine and mizoribine on aggregation of normal and uremic platelets.
    Malyszko JS; Malyszko J; Pawlak K; Mysliwiec M; Takada Y; Takada A
    Transplant Proc; 1996 Dec; 28(6):3488-9. PubMed ID: 8962356
    [No Abstract]   [Full Text] [Related]  

  • 5. Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular risk.
    Aggarwal A; Kabbani SS; Rimmer JM; Gennari FJ; Taatjes DJ; Sobel BE; Schneider DJ
    Am J Kidney Dis; 2002 Aug; 40(2):315-22. PubMed ID: 12148104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbacyclin derivative (CS-570). A new anticoagulant for hemodialysis.
    Suzuki T; Naganuma S; Takahashi K; Ota K
    ASAIO Trans; 1986; 32(1):291-6. PubMed ID: 3535844
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gallopamil and changes of adenosine diphosphate- and collagen-induced thrombocyte aggregation].
    Költringer P; Langsteger W; Lind P; Pierer G; Reisecker F; Eber O
    Arzneimittelforschung; 1991 Aug; 41(8):786-8. PubMed ID: 1781797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of ultrafiltrates in plasma from patients with chronic uremia on platelet aggregation].
    Myśliwiec M; Popławski A; Soszka J
    Pol Tyg Lek; 1991 Jan 21-28; 46(4-5):76-8. PubMed ID: 1845699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of latamoxef on platelet aggregation in hemodialysis and continuous ambulatory peritoneal dialysis (CAPD) patients].
    Inoue T; Sakaguchi K; Yoshida K; Imai T; Kajimoto Y; Shirai D
    Nihon Jinzo Gakkai Shi; 1986 Feb; 28(2):177-83. PubMed ID: 3735768
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of recombinant human erythropoietin on thrombocyte aggregation capacity and on the blood prostanoid level in patients with chronic kidney failure on hemodialysis].
    Rud'ko IA; Pokrovskiĭ IuA; Ermolenko VM; Kubatiev AA
    Ter Arkh; 1991; 63(10):128-30. PubMed ID: 1805410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of platelet function by increased frequency of hemodialysis.
    Lindsay RM; Friesen M; Aronstam A; Andrus F; Clark WF; Linton AL
    Clin Nephrol; 1978 Aug; 10(2):67-70. PubMed ID: 699401
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet function as an indicator of adequate dialysis.
    Rabiner SF; Drake RF
    Kidney Int Suppl; 1975 Jan; (2):144-6. PubMed ID: 1057672
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of vitamin E on platelet function and anemia in patients on long-term hemodialysis].
    Janicka L; Dmoszyńska A; Ksiazek A; Kozioł M
    Pol Tyg Lek; 1988 Nov; 43(48):1557-8. PubMed ID: 3255907
    [No Abstract]   [Full Text] [Related]  

  • 14. Correction of uremic platelet dysfunction after renal transplantation.
    Campistol JM; Cofan F; Díaz Ricart M; Tassies D; Cases A; Torregrosa JV; Ricart J; Vilardell J; Oppenheimer F; Escolar G
    Transplant Proc; 1995 Aug; 27(4):2244-5. PubMed ID: 7652791
    [No Abstract]   [Full Text] [Related]  

  • 15. "In vitro" inhibition of platelet aggregation by uremic middle molecules.
    Gallice P; Fournier N; Crevat A; Saingra S; Frayssinet R; Murisasco A; Sicardi F
    Biomedicine; 1980; 33(6):185-8. PubMed ID: 7213919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation before and after hemodialysis in chronic renal insufficiency.
    Kageyama T; Oyabu H; Tsumoto S; Kimoto S; Toda H
    Bull Osaka Med Sch; 1983 Oct; 29(2):62-8. PubMed ID: 6680327
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in plasmic and platelet hemostasis in patients with chronic renal failure in hemodialysis].
    Surovikina MS; Samoĭlenko VV; Vlasova EA; Vasilenko IA; Suslov VP
    Urologiia; 2012; (1):25-9. PubMed ID: 22645997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ADP and collagen-induced thrombocyte aggregation in umbilical cord vein blood].
    Briel RC; Kunz S; Zehles J
    Z Geburtshilfe Perinatol; 1983; 187(5):239-45. PubMed ID: 6685947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal blood loss in patients undergoing maintenance dialysis.
    Wizemann V; Buddensiek P; de Boor J; Grebe S; Schütterle G
    Kidney Int Suppl; 1983 Dec; 16():S218-20. PubMed ID: 6588252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Picotamide, selective inhibitor of thromboxane synthesis in patients on maintenance hemodialysis.
    Vandelli L; Grosoli M; Lusvarghi E; Cenci AM; Campioli D; Grossi G
    Nephrol Dial Transplant; 1989; 4(12):1083-4. PubMed ID: 2517331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.